What are Angiotensin II receptor antagonist drugs?

Angiotensin II receptor antagonist drugs are pharmacologic agents that share a common mechanism (typically targeting AT1 receptor). 3 are currently marketed, with 8 more in clinical development.

What are the marketed Angiotensin II receptor antagonist drugs?

Marketed Angiotensin II receptor antagonist drugs include group C, Alphintern® , tablet, Amoun, Egypt, Conversion schedule - Week 1.

Angiotensin II receptor antagonist

3 marketed 6 in Phase 3 1 in Phase 2 1 in Phase 1

This page covers all Angiotensin II receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting AT1 receptor.

Targets

AT1 receptor

Marketed (3)

group C · Kaohsiung Medical University Chung-Ho Memorial Hospital · Cardiovascular
This drug works by inhibiting the renin-angiotensin system to lower blood pressure.
Alphintern® , tablet, Amoun, Egypt · Ain Shams University · Cardiovascular
Alphintern is an antihypertensive agent that works by blocking the action of angiotensin II at its receptor sites, thereby reducing blood pressure.
Conversion schedule - Week 1 · St. Joseph's Hospital and Medical Center, Phoenix · Cardiovascular
This drug is used to treat hypertension by blocking the action of angiotensin II at its receptor.

Phase 3 pipeline (6)

TA-7284 High · Tanabe Pharma Corporation · Cardiovascular
TA-7284 High is a drug that targets the renin-angiotensin system.
Micardis Anlo · EMS · Cardiovascular
Micardis Anlo is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to lower blood pressure.
AGT4 · Ahn-Gook Pharmaceuticals Co.,Ltd · Cardiovascular
AGT4 is an angiotensin II receptor antagonist.
Olmesartan medoxomil tablets high dose · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · Cardiovascular
Olmesartan medoxomil is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, thereby lowering blood pressure.
Placebo to losartan potassium · Merck Sharp & Dohme LLC · Cardiovascular
Losartan potassium is an angiotensin II receptor antagonist that blocks the action of angiotensin II at its receptor in the blood vessels, causing them to relax and dilate, which lowers blood pressure and reduces the workload on the heart.
Placebo Eprosartan mesylate · Abbott · Cardiovascular
Eprosartan mesylate is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to lower blood pressure.

Phase 2 pipeline (1)

BR1400-A · Boryung Pharmaceutical Co., Ltd · Cardiovascular
BR1400-A is a small molecule that targets the renin-angiotensin system.

Phase 1 pipeline (1)

Active hypertension medical therapy · Verve Medical, Inc · Cardiovascular
Blocks the action of angiotensin II at the AT1 receptor